Related references
Note: Only part of the references are listed.Replication of MAPT and SNCA, but not PARK16-18, as Susceptibility Genes for Parkinson's Disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2011)
The effect of SNCA 3' region on the levels of SNCA-112 splicing variant
Jeanette J. McCarthy et al.
NEUROGENETICS (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
SNP rs7684318 of the α-synuclein gene is associated with Parkinson's disease in the Han Chinese population
Lihua Yu et al.
BRAIN RESEARCH (2010)
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Epaminondas Doxakis
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
Neuropothological assessment of Parkinson's disease: refining the diagnostic criteria. (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
Adenosine deamination in human transcripts generates novel microRNA binding sites
Glen M. Borchert et al.
HUMAN MOLECULAR GENETICS (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease
Sotiria Sotiriou et al.
NEUROSCIENCE LETTERS (2009)
Repression of α-synuclein expression and toxicity by microRNA-7
Eunsung Junn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Dennis W. Dickson et al.
LANCET NEUROLOGY (2009)
Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population
R. Myhre et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein
Gaofeng Wang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
I Mizuta et al.
HUMAN MOLECULAR GENETICS (2006)
LRRK2 mutations are a common cause of Parkinson's disease in Spain
IF Mata et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Multiple regions of α-synuclein are associated with Parkinson's disease
JC Mueller et al.
ANNALS OF NEUROLOGY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
α-synuclein promoter confers susceptibility to Parkinson's disease
P Pals et al.
ANNALS OF NEUROLOGY (2004)
Genetic and environmental factors in the cause of Parkinson's disease
TT Warner et al.
ANNALS OF NEUROLOGY (2003)
Analysis of the coding and the 5′ flanking regions of the α-synuclein gene in patients with Parkinson's disease
P Pastor et al.
MOVEMENT DISORDERS (2001)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
